Skip to content
  • Publications
  • Training
  • FAQs
  • M&E Dashboard
  • Vacancies
Menu
  • Publications
  • Training
  • FAQs
  • M&E Dashboard
  • Vacancies
Contact
  • COVID-19
    • SARS-COV-2 Rapid Test Reporting
    • TrakCare Lab Webview
    • COVID-19 Frequently Asked Questions
    • COVID-19 Returning to Work FAQs
    • COVID-19 Surveillance Reports
    • COVID-19 Vaccine
    • Variant Tracking in South Africa
    • COVID-19 Technical Resources
    • COVID-19 Guidelines
    • COVID-19 Advice for The Public
    • COVID-19 Prevention
    • COVID-19 Advice for Travellers
    • Long COVID
    • COVID-19 Vaccine Breakthrough Cases Frequently Asked Questions
    • COVID-19 Resources for Children
    • COVID-19 Communication Resources
    • COVID-19 Contact Resources
  • About Us
    • Overview
    • Our Objectives
    • Management
    • Our Partners
    • Data protection and privacy policy
  • Centres
    • Centre for Emerging Zoonotic and Parasitic Diseases
    • Centre for Enteric Diseases
    • Centre for Healthcare-Associated Infections, Antimicrobial Resistance and Mycoses
    • Centre for HIV and STIs
    • Centre for Respiratory Diseases and Meningitis
    • Centre for Tuberculosis
    • Centre for Vaccines and Immunology
    • Division of Public Health, Surveillance and Response
    • National Cancer Registry
      • Cancer Statistics
    • Transversal Functions
  • Our Services
    • Surveillance
    • Training
    • Outbreak Response
    • Research
    • Proficiency Testing Schemes
    • Diagnostic Services
  • Notifiable Medical Conditions
    • Overview
    • Notification Process
    • Tutorial Videos
    • Notification Forms
    • NMC COVID-19 Documents
    • Contacts
  • Media
    • Alerts
    • News
    • Videos
    • Podcasts
    • Blogs
Menu
  • COVID-19
    • SARS-COV-2 Rapid Test Reporting
    • TrakCare Lab Webview
    • COVID-19 Frequently Asked Questions
    • COVID-19 Returning to Work FAQs
    • COVID-19 Surveillance Reports
    • COVID-19 Vaccine
    • Variant Tracking in South Africa
    • COVID-19 Technical Resources
    • COVID-19 Guidelines
    • COVID-19 Advice for The Public
    • COVID-19 Prevention
    • COVID-19 Advice for Travellers
    • Long COVID
    • COVID-19 Vaccine Breakthrough Cases Frequently Asked Questions
    • COVID-19 Resources for Children
    • COVID-19 Communication Resources
    • COVID-19 Contact Resources
  • About Us
    • Overview
    • Our Objectives
    • Management
    • Our Partners
    • Data protection and privacy policy
  • Centres
    • Centre for Emerging Zoonotic and Parasitic Diseases
    • Centre for Enteric Diseases
    • Centre for Healthcare-Associated Infections, Antimicrobial Resistance and Mycoses
    • Centre for HIV and STIs
    • Centre for Respiratory Diseases and Meningitis
    • Centre for Tuberculosis
    • Centre for Vaccines and Immunology
    • Division of Public Health, Surveillance and Response
    • National Cancer Registry
      • Cancer Statistics
    • Transversal Functions
  • Our Services
    • Surveillance
    • Training
    • Outbreak Response
    • Research
    • Proficiency Testing Schemes
    • Diagnostic Services
  • Notifiable Medical Conditions
    • Overview
    • Notification Process
    • Tutorial Videos
    • Notification Forms
    • NMC COVID-19 Documents
    • Contacts
  • Media
    • Alerts
    • News
    • Videos
    • Podcasts
    • Blogs
Search
Close
Search
Close
  • OVERVIEW
  • OUR OBJECTIVES
  • MANAGEMENT
  • OUR PARTNERS
  • DATA PROTECTION AND PRIVACY POLICY
Menu
  • OVERVIEW
  • OUR OBJECTIVES
  • MANAGEMENT
  • OUR PARTNERS
  • DATA PROTECTION AND PRIVACY POLICY

Pseudomonas aeruginosa

Diseases A-Z Index Pseudomonas aeruginosa

Diseases A-Z Index:
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • W
  • V
  • X
  • Y
  • Z

What is Pseudomonas aeruginosa? 

Pseudomonas aeruginosa is a Gram-negative, rod-shaped bacterium. P. aeruginosa is a ubiquitous microorganism, which means it has the ability to survive under a variety of environmental conditions. It is commonly found in the environment e.g. water and soil. It causes disease in plants, animals and humans where it is an opportunistic pathogen, affecting patients when the immune system is weakened. P. aeruginosa causes dermatitis, soft tissue infections, bone and joint infections, urinary tract infections (UTIs), gastrointestinal infections, respiratory system infections, bloodstream infections and a variety of systemic infections, mainly in patients with severe burns, cancer and AIDS. As it has an extensive range of resistance mechanisms, P. aeruginosa is frequently resistant to common antibiotics making the treatment of infections challenging. Antimicrobial resistance has led to a serious restriction in treatment options. This pathogen can cause healthcare-associated infections (HAIs).

Share

Share on facebook
Share on twitter
Facebook Instagram Linkedin Twitter Youtube

Quick Links

  • M&E Dashboard
  • Publications
  • Vacancies
  • Researcher Directory
  • Terms and Conditions

Download NMC

  • Android App
  • Huawei App
  • Web Portal
  • Apple App

Connect with our Researchers

Contact Us

© NICD 2021. All Rights Reserved
Disclaimer: The National Institute for Communicable Diseases does not provide Medical Advice to the public. For Medical Advice, please consult your Healthcare provider.